Reviewed Mar 2026 | Sources: PubMed

Selank vs Semax: Head-to-Head Comparison

Selank and Semax are both Russian-developed regulatory peptides approved in Russia for clinical use. Selank is an anxiolytic based on tuftsin (an immune peptide), while Semax is a nootropic based on ACTH(4-10). Selank targets anxiety and stress; Semax targets cognition and neuroprotection.

Side-by-Side Comparison

DimensionSelankSemax
Evidence LevelApproved in Russia; multiple Russian clinical studiesApproved in Russia; extensive Russian clinical and preclinical data
FDA StatusNot approved in US/EUNot approved in US/EU
MechanismGABA modulation, serotonin metabolism, immune modulation (tuftsin analog)BDNF upregulation, dopamine/serotonin modulation (ACTH fragment)
Primary UseAnxiety, stress, immune supportCognitive enhancement, stroke recovery, neuroprotection
Side EffectsVery well-tolerated; mild fatigue possibleWell-tolerated; mild irritation with nasal use
Route of AdministrationIntranasal dropsIntranasal drops
OnsetAnxiolytic effects within minutes to hoursCognitive effects noticeable within hours
Evidence Level
Selank
Approved in Russia; multiple Russian clinical studies
Semax
Approved in Russia; extensive Russian clinical and preclinical data
FDA Status
Selank
Not approved in US/EU
Semax
Not approved in US/EU
Mechanism
Selank
GABA modulation, serotonin metabolism, immune modulation (tuftsin analog)
Semax
BDNF upregulation, dopamine/serotonin modulation (ACTH fragment)
Primary Use
Selank
Anxiety, stress, immune support
Semax
Cognitive enhancement, stroke recovery, neuroprotection
Side Effects
Selank
Very well-tolerated; mild fatigue possible
Semax
Well-tolerated; mild irritation with nasal use
Route of Administration
Selank
Intranasal drops
Semax
Intranasal drops
Onset
Selank
Anxiolytic effects within minutes to hours
Semax
Cognitive effects noticeable within hours

Peptide Overviews

Selank

BHuman Studies

Selank is a synthetic peptide developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is approved in Russia as an anxiolytic and nootropic medication.

Sleep & StressNot Approved
View full Selank profile →

Semax

BHuman Studies

Semax is a synthetic peptide derived from the ACTH(4-10) fragment, developed in Russia as a nootropic and neuroprotective agent. It is approved in Russia for stroke, cognitive disorders, and optic nerve disease.

Cognitive EnhancementNot Approved
View full Semax profile →

Selank vs Semax: FAQ

Stay Informed on Peptide Research

Get weekly comparison updates, new study alerts, and regulatory changes.

No spam. Unsubscribe anytime.

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.